According to clinical trial results, immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo.
In February, these results were shared in a late-breaking oral presentation at the American Society of Clinical Oncology (ASCO) 2023 Genitourinary Cancers Symposium.
Matthew Galsky, MD, Co-Director of the Center of…
Read full story at NepalNews.com
Add comment